pyrroles has been researched along with B16 Melanoma in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (15.38) | 18.2507 |
| 2000's | 6 (23.08) | 29.6817 |
| 2010's | 15 (57.69) | 24.3611 |
| 2020's | 1 (3.85) | 2.80 |
| Authors | Studies |
|---|---|
| Babar, DA; Chopra, S; Kalari, S; Karale, UB; Kaul, G; Makane, VB; Misra, S; Rekha, EM; Rode, HB; Shukla, M; Sriram, D; Vamshi Krishna, E | 1 |
| Anderson, KC; Dimasi, N; Gregson, SJ; Herbst, R; Howard, PW; Kiefer, CM; Kinneer, K; Masterson, L; Meekin, J; Moriarty, A; Papadopoulos, KP; Phipps, S; Rebelatto, MC; Sridhar, S; Tai, YT; Tiberghien, AC; Tice, DA; Wick, MJ | 1 |
| Hyun, H; Lyle, LT; Pang, L; Pei, Y; Uzunalli, G; Yeo, Y | 1 |
| Deng, GH; Jiang, Y; Liu, J; Peng, XC; Wang, Y; Wei, YQ; Zhang, J | 1 |
| Agrawal, V; Kim, J; Kim, K; Kim, YM; Kwon, YG; Lee, K; Lee, S; Park, H; Suh, YG | 1 |
| Cooray, SN; Gobbetti, T; Jonassen, TE; Montero-Melendez, T; Perretti, M | 1 |
| Bollag, G; Graeber, TG; Hu-Lieskovan, S; Koya, RC; Mok, S; Ribas, A; Tsoi, J; West, BL | 1 |
| Biswas, S; Byzova, TV; Crabb, JW; Gao, D; Gugiu, GB; Kim, YW; Podrez, EA; Renganathan, K; Salomon, RG; West, XZ; Yakubenko, VP | 1 |
| Dimberg, A; Georganaki, M; Huang, H; Mangsbo, SM; van Hooren, L | 1 |
| Jalkanen, S; Joensuu, H; Laukkanen, MO; Laurila, JP; Salmi, M | 1 |
| Brar, KK; Gaither, KA; Garcia, SR; Little, AA; McBride, AA; Meadows, GG; Platt, A; Zhang, F; Zhang, H; Zhu, Z | 1 |
| Alonso, J; Cardier, JE; Ledezma, E; Wittig, O | 1 |
| Deng, J; Figlin, R; Forman, S; Herrmann, A; Jensen, M; Kujawski, M; Reckamp, K; Scuto, A; Yu, H; Zhang, C | 1 |
| Alber, S; Bose, A; Cohen, PA; Finke, JH; Garcia, JA; Ko, JS; Rini, BI; Storkus, WJ; Taylor, JL; Watkins, SC | 1 |
| Baryshnikov, A; Grigorieva, I; Lichinitser, M; Solomko, E; Stepanova, E; Vartanian, A | 1 |
| Almenara, J; Alotaibi, M; Biggers, JW; Brown, R; Di, X; Emery, SM; Gewirtz, DA; Gupton, JT; Henderson, SC; Nguyen, T; White, KL | 1 |
| Bailey-Downs, LC; Gangjee, A; Ihnat, MA; Namjoshi, OA; Thorpe, JE; Yu, J | 1 |
| Hartley, JA; Hudson, S; Kiakos, K; Lee, M; Lingerfelt, B; Purnell, B; Scott, A; Summerville, K; Townes, H | 1 |
| Favre, G; Leveque, K; Sarrabayrouse, G; Synaeve, C; Tilkin-Mariamé, AF | 1 |
| Anke, H; Hamprecht, G; Hanefeld, U; Kellner, M; Kraemer, HP; Laatsch, H; Pudleiner, H; Renneberg, B | 1 |
| Abraham, I; McCroskey, MC; Sampson, KE | 1 |
| Ito, S; Wakamatsu, K | 1 |
| Aiello, E; Almerico, AM; Cirrincione, G; Crosta, L; Dattolo, G; Diana, P; Dusonchet, L; Grimaudo, S; Rausa, L; Tolomeo, M | 1 |
| Edatsugi, H; Matsuba, Y; Matsunaga, A; Mita, I; Nakanishi, O | 1 |
| Donnelly, E; Geng, L; Hallahan, DE; Lin, PC; McMahon, G; Oshinka, H; Sierra-Rivera, E | 1 |
| Dellian, M; Goetz, AE; Harris, AG; Krasnici, S; Messmer, K; Pahernik, S; Schmitt-Sody, M | 1 |
26 other study(ies) available for pyrroles and B16 Melanoma
| Article | Year |
|---|---|
Synthesis of novel 4,5-dihydropyrrolo[1,2-a]quinoxalines, pyrrolo[1,2-a]quinoxalin]-2-ones and their antituberculosis and anticancer activity.
Topics: A549 Cells; Antineoplastic Agents; Antitubercular Agents; Cell Survival; Dose-Response Relationship, Drug; Drug Design; HeLa Cells; Hep G2 Cells; Humans; Inhibitory Concentration 50; MCF-7 Cells; Melanoma, Experimental; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Neoplasms; Pyrroles; Quinoxalines; Structure-Activity Relationship | 2020 |
SLC46A3 as a Potential Predictive Biomarker for Antibody-Drug Conjugates Bearing Noncleavable Linked Maytansinoid and Pyrrolobenzodiazepine Warheads.
Topics: Animals; Antineoplastic Agents, Immunological; Benzodiazepines; Biomarkers; Cell Line, Tumor; Disease Models, Animal; Gene Expression; Gene Silencing; Humans; Immunoconjugates; Maytansine; Melanoma, Experimental; Mice; Pyrroles; Xenograft Model Antitumor Assays | 2018 |
Surface Modification of Polymeric Nanoparticles with M2pep Peptide for Drug Delivery to Tumor-Associated Macrophages.
Topics: Aminopyridines; Animals; Cell Line; Cell Line, Tumor; Drug Carriers; Drug Delivery Systems; Humans; Macrophages; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Nanoparticles; Peptides; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Pyrroles; RAW 264.7 Cells | 2019 |
Exogenous norepinephrine attenuates the efficacy of sunitinib in a mouse cancer model.
Topics: Adrenergic alpha-Agonists; Angiogenesis Inhibitors; Animals; Cell Line, Tumor; Drug Screening Assays, Antitumor; Female; Humans; Indoles; Inhibitory Concentration 50; Interleukin-6; Interleukin-8; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Norepinephrine; Propranolol; Pyrroles; Receptors, Adrenergic, beta; Signal Transduction; Sunitinib; Tumor Burden; Vascular Endothelial Growth Factor A | 2014 |
Combined effect of vascular-leakage-blocker Sac-1004 and antiangiogenic drug sunitinib on tumor angiogenesis.
Topics: Angiogenesis Inhibitors; Animals; Cell Line, Tumor; Drug Therapy, Combination; Indoles; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Pyrroles; Saponins; Sunitinib | 2014 |
Biased agonism as a novel strategy to harness the proresolving properties of melanocortin receptors without eliciting melanogenic effects.
Topics: Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Calcium; Disease Models, Animal; Gene Knockout Techniques; Guanidines; HEK293 Cells; Humans; Inflammation; Macrophages, Peritoneal; Male; Melanins; Melanoma, Experimental; Mice; Neutrophils; Peritonitis; Phagocytosis; Pyrroles; Receptor, Melanocortin, Type 1; Receptor, Melanocortin, Type 3; Receptors, Melanocortin; Signal Transduction | 2015 |
Inhibition of colony stimulating factor-1 receptor improves antitumor efficacy of BRAF inhibition.
Topics: Aminopyridines; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Drug Screening Assays, Antitumor; Drug Synergism; Indoles; Lymphocyte Activation; Macrophages; Melanoma, Experimental; Mice, Inbred C57BL; Mice, Inbred NOD; Mice, SCID; Neoplasm Transplantation; Proto-Oncogene Proteins B-raf; Pyrroles; Receptor, Macrophage Colony-Stimulating Factor; Sulfonamides; T-Lymphocytes; Vemurafenib | 2015 |
Receptor-Mediated Mechanism Controlling Tissue Levels of Bioactive Lipid Oxidation Products.
Topics: Animals; Antigens, Differentiation; Apolipoproteins E; Atherosclerosis; CD36 Antigens; Disease Models, Animal; HEK293 Cells; Humans; Lipoproteins, LDL; Macrophages, Peritoneal; Melanoma, Experimental; Mice, Inbred C57BL; Mice, Knockout; Neovascularization, Physiologic; Oxidative Stress; Phenotype; Pyrroles; RNA Interference; Signal Transduction; Time Factors; Toll-Like Receptor 2; Transfection; Tumor Burden; Wound Healing | 2015 |
Sunitinib enhances the antitumor responses of agonistic CD40-antibody by reducing MDSCs and synergistically improving endothelial activation and T-cell recruitment.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents; CD11b Antigen; CD40 Antigens; Cell Line, Tumor; Dendritic Cells; Drug Synergism; Endothelial Cells; Fibrosarcoma; Indoles; Intercellular Adhesion Molecule-1; Kaplan-Meier Estimate; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Myeloid-Derived Suppressor Cells; Pyrroles; Sunitinib; T-Lymphocytes, Cytotoxic; Up-Regulation; Vascular Cell Adhesion Molecule-1 | 2016 |
Leukocyte trafficking is not affected by multikinase inhibitors sunitinib or sorafenib in mice.
Topics: Animals; Cell Movement; Female; Indoles; Leukocytes; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, SCID; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyrroles; Sorafenib; Sunitinib; T-Lymphocytes, Regulatory; Transendothelial and Transepithelial Migration | 2016 |
The immunomodulatory, antitumor and antimetastatic responses of melanoma-bearing normal and alcoholic mice to sunitinib and ALT-803: a combinatorial treatment approach.
Topics: Alcoholism; Animals; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Female; Indoles; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Proteins; Pyrroles; Recombinant Fusion Proteins; Sunitinib; T-Lymphocytes, Regulatory | 2016 |
Potentiated cytotoxic effects of statins and ajoene in murine melanoma cells.
Topics: Animals; Apoptosis; Atorvastatin; Cell Line, Tumor; Disulfides; Drug Screening Assays, Antitumor; Drug Synergism; Flow Cytometry; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Melanocytes; Melanoma, Experimental; Mevalonic Acid; Mice; Polyisoprenyl Phosphates; Pravastatin; Pyrroles; Sulfoxides; Terpenes | 2009 |
Targeting STAT3 in adoptively transferred T cells promotes their in vivo expansion and antitumor effects.
Topics: Animals; Antineoplastic Agents; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Cell Proliferation; Combined Modality Therapy; Dendritic Cells; Female; Immunotherapy, Adoptive; Indoles; Lymphocytes, Tumor-Infiltrating; Male; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Pyrroles; STAT3 Transcription Factor; Sunitinib; T-Lymphocytes, Regulatory; Tumor Burden | 2010 |
Sunitinib facilitates the activation and recruitment of therapeutic anti-tumor immunity in concert with specific vaccination.
Topics: Animals; Antibodies, Blocking; Cancer Vaccines; Cell Line, Tumor; Combined Modality Therapy; Dendritic Cells; Epitopes, T-Lymphocyte; Female; Immunotherapy, Adoptive; Indoles; Lymph Nodes; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Pyrroles; Receptors, CXCR3; Sunitinib; T-Lymphocytes; Tumor Microenvironment; Vascular Cell Adhesion Molecule-1 | 2011 |
VEGFR1 and PKCα signaling control melanoma vasculogenic mimicry in a VEGFR2 kinase-independent manner.
Topics: Animals; Cell Line, Tumor; Female; Humans; Indoles; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Protein Kinase C-alpha; Pyrroles; RNA, Small Interfering; Signal Transduction; Skin Neoplasms; Transfection; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2 | 2011 |
Autophagy, cell death and sustained senescence arrest in B16/F10 melanoma cells and HCT-116 colon carcinoma cells in response to the novel microtubule poison, JG-03-14.
Topics: Animals; Apoptosis; Autophagy; Cellular Senescence; Colonic Neoplasms; HCT116 Cells; Humans; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Microtubules; Peripheral Nervous System Diseases; Pyrroles | 2013 |
N2-Trimethylacetyl substituted and unsubstituted-N4-phenylsubstituted-6-(2-pyridin-2-ylethyl)-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamines: design, cellular receptor tyrosine kinase inhibitory activities and in vivo evaluation as antiangiogenic, antimetastati
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Drug Design; Humans; Melanoma, Experimental; Mice; Mice, Nude; Microwaves; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Receptor Protein-Tyrosine Kinases; Structure-Activity Relationship | 2013 |
Novel (S)-(-)- and R-(+)-seco-iso-cyclopropylfurano[e]indoline-5,6,7-trimethoxyindole-2-carboxamide (iso-CFI) analogs of duocarmycin C2: synthesis and biological evaluation.
Topics: Animals; Antineoplastic Agents, Alkylating; Base Sequence; Cell Proliferation; DNA; Drug Screening Assays, Antitumor; Duocarmycins; Heterocyclic Compounds, 3-Ring; Indoles; Leukemia L1210; Melanoma, Experimental; Mice; Models, Chemical; Pyrroles; Stereoisomerism; Tumor Cells, Cultured | 2006 |
Statins stimulate in vitro membrane FasL expression and lymphocyte apoptosis through RhoA/ROCK pathway in murine melanoma cells.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; ADP Ribose Transferases; Amino Acid Chloromethyl Ketones; Animals; Apoptosis; Atorvastatin; Benzamides; Botulinum Toxins; Cell Line, Tumor; Fas Ligand Protein; fas Receptor; Gene Expression Regulation, Neoplastic; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lymphocytes; Lymphoma; Melanoma, Experimental; Membrane Proteins; Methionine; Mevalonic Acid; Mice; Pyrroles; Recombinant Fusion Proteins; rho GTP-Binding Proteins; rho-Associated Kinases; rhoA GTP-Binding Protein; RNA, Small Interfering | 2007 |
Structure-activity relationships of phenyl- and benzoylpyrroles.
Topics: Animals; Anti-Infective Agents; Antineoplastic Agents; Female; Hydrogen Bonding; Lethal Dose 50; Leukemia L1210; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Plants; Pyrroles; Structure-Activity Relationship | 1995 |
Identification of a 170 kDa membrane kinase with increased activity in KB-V1 multidrug resistant cells.
Topics: Alkaloids; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Calcium; Carbazoles; Carrier Proteins; Clone Cells; Cyclic AMP; Drug Resistance; Electrophoresis, Polyacrylamide Gel; Humans; Indole Alkaloids; Indoles; KB Cells; Melanoma, Experimental; Membrane Glycoproteins; Mice; Neoplasm Proteins; Phosphatidylserines; Phosphorylation; Phosphothreonine; Phosphotyrosine; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Pyrroles; Staurosporine; Transfection; Tumor Cells, Cultured; Tyrosine | 1993 |
An improved modification of permanganate oxidation of eumelanin that gives a constant yield of pyrrole-2,3,5-tricarboxylic acid.
Topics: Animals; Chromatography, High Pressure Liquid; Hair; Humans; Liver; Melanins; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Oxidation-Reduction; Potassium Permanganate; Pyrroles; Tumor Cells, Cultured | 1994 |
3-Triazenopyrroles: synthesis and antineoplastic activity.
Topics: Animals; Antineoplastic Agents; Cell Survival; Friend murine leukemia virus; Lethal Dose 50; Leukemia, Erythroblastic, Acute; Melanoma, Experimental; Mice; Mice, Inbred DBA; Pyrroles; Triazines; Tumor Cells, Cultured | 1993 |
A novel synthetic DNA minor groove binder, MS-247: antitumor activity and cytotoxic mechanism.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Benzimidazoles; Cell Survival; Cisplatin; Colonic Neoplasms; DNA; Female; Fluorescent Dyes; Humans; Leukemia L1210; Leukemia P388; Macromolecular Substances; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Paclitaxel; Pyrroles; Radiation-Sensitizing Agents | 2000 |
Inhibition of vascular endothelial growth factor receptor signaling leads to reversal of tumor resistance to radiotherapy.
Topics: Angiogenesis Inhibitors; Animals; Cell Survival; Dose-Response Relationship, Radiation; Endothelial Growth Factors; Endothelium, Vascular; Enzyme Inhibitors; Glioblastoma; Indoles; Lymphokines; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Pyrroles; Radiation Tolerance; Receptor Protein-Tyrosine Kinases; Receptors, Growth Factor; Receptors, Vascular Endothelial Growth Factor; Signal Transduction; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2001 |
Orthogonal polarisation spectral imaging as a new tool for the assessment of antivascular tumour treatment in vivo: a validation study.
Topics: Angiogenesis Inhibitors; Animals; Blood Flow Velocity; Capillaries; Cricetinae; Erythrocytes; Hemoglobins; Image Processing, Computer-Assisted; Indoles; Male; Melanoma, Experimental; Mesocricetus; Microcirculation; Microscopy, Fluorescence; Microscopy, Polarization; Pyrroles; Skin Window Technique | 2002 |